AbbVie Inc.
ABBV
$225.11
-$2.59-1.14%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.29% | 15.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.29% | 15.59% | |||
| Cost of Revenue | 2.55% | 8.60% | |||
| Gross Profit | 2.18% | 18.58% | |||
| SG&A Expenses | 7.70% | -0.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.60% | 3.80% | |||
| Operating Income | -3.23% | 42.54% | |||
| Income Before Tax | -54.05% | -6.44% | |||
| Income Tax Expenses | -14.19% | 64.78% | |||
| Earnings from Continuing Operations | -80.02% | -27.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 33.33% | 0.00% | |||
| Net Income | -80.17% | -27.06% | |||
| EBIT | -3.23% | 42.54% | |||
| EBITDA | -2.22% | 28.50% | |||
| EPS Basic | -81.04% | -27.27% | |||
| Normalized Basic EPS | -1.28% | 51.13% | |||
| EPS Diluted | -80.87% | -27.78% | |||
| Normalized Diluted EPS | -1.28% | 51.23% | |||
| Average Basic Shares Outstanding | 0.06% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.06% | -0.06% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 4.04% | 0.36% | |||